Junlong Ma

490 total citations
50 papers, 320 citations indexed

About

Junlong Ma is a scholar working on Physiology, Oncology and Electrical and Electronic Engineering. According to data from OpenAlex, Junlong Ma has authored 50 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Oncology and 7 papers in Electrical and Electronic Engineering. Recurrent topics in Junlong Ma's work include Synthesis and Properties of Aromatic Compounds (5 papers), Pain Mechanisms and Treatments (5 papers) and Pharmacovigilance and Adverse Drug Reactions (4 papers). Junlong Ma is often cited by papers focused on Synthesis and Properties of Aromatic Compounds (5 papers), Pain Mechanisms and Treatments (5 papers) and Pharmacovigilance and Adverse Drug Reactions (4 papers). Junlong Ma collaborates with scholars based in China, Singapore and Philippines. Junlong Ma's co-authors include Guoping Yang, Heng Chen, Gaoyun Hu, Zhuo Chen, Pan Huang, Chengbin Wang, Song Han, Guo-Ming Shen, Qianbin Li and Hao Wang and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and Journal of Agricultural and Food Chemistry.

In The Last Decade

Junlong Ma

42 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junlong Ma China 10 90 48 37 35 25 50 320
Ignacio Montorfano Chile 10 171 1.9× 36 0.8× 26 0.7× 41 1.2× 61 2.4× 11 462
Junhua Zhuang China 11 109 1.2× 30 0.6× 33 0.9× 12 0.3× 45 1.8× 37 338
Hwan Hee Lee South Korea 13 119 1.3× 47 1.0× 31 0.8× 16 0.5× 36 1.4× 23 349
Vincent Nuyens Belgium 12 161 1.8× 44 0.9× 22 0.6× 13 0.4× 51 2.0× 32 410
Lu Xu China 12 152 1.7× 25 0.5× 47 1.3× 13 0.4× 60 2.4× 65 410
Wei Bi China 13 155 1.7× 48 1.0× 20 0.5× 117 3.3× 24 1.0× 30 498
Peng Du China 14 134 1.5× 35 0.7× 32 0.9× 12 0.3× 64 2.6× 33 467
Rishabh Dev India 12 94 1.0× 39 0.8× 23 0.6× 22 0.6× 38 1.5× 39 380
Lili Zhu China 10 104 1.2× 19 0.4× 35 0.9× 11 0.3× 35 1.4× 25 250

Countries citing papers authored by Junlong Ma

Since Specialization
Citations

This map shows the geographic impact of Junlong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junlong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junlong Ma more than expected).

Fields of papers citing papers by Junlong Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junlong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junlong Ma. The network helps show where Junlong Ma may publish in the future.

Co-authorship network of co-authors of Junlong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Junlong Ma. A scholar is included among the top collaborators of Junlong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junlong Ma. Junlong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Yu, Yangyang Zhang, Hong‐Guang Jin, et al.. (2025). Giant Cycloparaphenylene‐Scaffolded Porphyrins as Photocatalysts. Angewandte Chemie. 138(5).
2.
Yan, Xin, Junlong Ma, Chengxian Guo, & Guoping Yang. (2025). Association of antibiotics with Stevens–Johnson syndrome and toxic epidermal necrolysis: A real-world pharmacovigilance study. International Journal of Antimicrobial Agents. 66(2). 107524–107524. 2 indexed citations
3.
Ren, Yu, Yangyang Zhang, Hong‐Guang Jin, et al.. (2025). Giant Cycloparaphenylene‐Scaffolded Porphyrins as Photocatalysts. Angewandte Chemie International Edition. 65(5). e22603–e22603. 1 indexed citations
4.
Wu, Qian, Feng Wu, Han Jiang, et al.. (2025). Safety Evaluation of Nitroimidazole Antibiotics Based on the FAERS Database. Clinical and Experimental Pharmacology and Physiology. 52(12). e70084–e70084.
6.
Ma, Junlong, et al.. (2025). Comprehensive analysis of adverse events associated with T-cell engagers using the FAERS database. Expert Opinion on Drug Safety. 24(7). 821–830. 4 indexed citations
7.
Chen, Heng & Junlong Ma. (2025). Post-marketing Safety Evaluation of Lutathera (177Lu-DOTATATE). Clinical Nuclear Medicine. 50(8). 714–720.
8.
Peng, Zhengwei, et al.. (2025). Enhanced Control for Diffusion Bridge in Image Restoration. 1–5. 1 indexed citations
10.
Ma, Junlong, et al.. (2024). Cardiovascular Adverse Events Associated with Tumor Necrosis Factor-Alpha Inhibitors: A Real-World Pharmacovigilance Analysis. Journal of Atherosclerosis and Thrombosis. 31(12). 1733–1747. 6 indexed citations
11.
Zhang, Lian, et al.. (2024). Performance analysis of a novel small-scale integrated solar-ORC system for power and heating. Solar Energy. 274. 112605–112605. 9 indexed citations
12.
Ma, Junlong, Yaxin Liu, Yuanyuan Sun, Chengxian Guo, & Guoping Yang. (2024). Increased Pneumonia Risk Associated with Concomitant Use of Inhaled Corticosteroids and Benzodiazepines: A Pharmacovigilance Analysis. Lung. 202(5). 673–681. 1 indexed citations
13.
Ma, Junlong, Heng Chen, Ji Sun, et al.. (2024). Efficient analysis of drug interactions in liver injury: a retrospective study leveraging natural language processing and machine learning. BMC Medical Research Methodology. 24(1). 312–312. 3 indexed citations
14.
Chen, Heng, et al.. (2024). Ocular adverse events associated with antibody-drug conjugates: a comprehensive pharmacovigilance analysis. Frontiers in Immunology. 15. 1495137–1495137. 4 indexed citations
15.
Ma, Junlong, Jie Huang, Chan Zou, et al.. (2023). A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Novel Intravenous Formulation of Meloxicam (QP001) in Healthy Chinese Subjects. Drug Design Development and Therapy. Volume 17. 2303–2313. 2 indexed citations
16.
Hu, Kai, Junlong Ma, Xin Huang, et al.. (2023). Association of Antipsychotic Drugs with Venous Thromboembolism: Data Mining of Food and Drug Administration Adverse Event Reporting System and Mendelian Randomization Analysis. Journal of Atherosclerosis and Thrombosis. 31(4). 396–418. 2 indexed citations
17.
Zhang, Zhenyu, et al.. (2023). Online correction of the transient voltage security region boundary based on load parameter variations in power systems. Frontiers in Energy Research. 11. 1 indexed citations
18.
Ma, Junlong, et al.. (2021). LncRNA ELFN1-AS1 Promotes Retinoblastoma Growth and Invasion via Regulating miR-4270/SBK1 Axis. Cancer Management and Research. Volume 13. 1067–1073. 19 indexed citations
19.
Ma, Junlong, et al.. (2020). Acupuncture attenuates the development of diabetic peripheral neuralgia by regulating P2X4 expression and inflammation in rat spinal microglia. The Journal of Physiological Sciences. 70(1). 45–45. 24 indexed citations
20.
Ma, Junlong, Heng Chen, Jie Yang, et al.. (2019). Binding pocket-based design, synthesis and biological evaluation of novel selective BRD4-BD1 inhibitors. Bioorganic & Medicinal Chemistry. 27(9). 1871–1881. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026